| Literature DB >> 26591009 |
Raimunda Sâmia Nogueira Brilhante1, Anderson Messias Rodrigues2, José Júlio Costa Sidrim3, Marcos Fábio Gadelha Rocha3, Sandro Antonio Pereira4, Isabella Dib Ferreira Gremião4, Tânia Maria Pacheco Schubach4, Zoilo Pires de Camargo2.
Abstract
Sporotrichosis is an important subcutaneous mycosis of humans and animals. Classically, the disease is acquired upon traumatic inoculation of Sporothrix propagules from contaminated soil and plant debris. In addition, the direct horizontal transmission of Sporothrix among animals and the resulting zoonotic infection in humans highlight an alternative and efficient rout of transmission through biting and scratching. Sporothrix brasiliensis is the most virulent species of the Sporothrix schenckii complex and is responsible for the long-lasting outbreak of feline sporotrichosis in Brazil. However, antifungal susceptibility data of animal-borne isolates is scarce. Therefore, this study evaluated the in vitro activity of amphotericin B, caspofungin, itraconazole, voriconazole, fluconazole, and ketoconazole against animal-borne isolates of S. brasiliensis. The susceptibility tests were performed through broth microdilution (M38-A2). The results show the relevant activity of itraconazole, amphotericin B, and ketoconazole against S. brasiliensis, with the following MIC ranges: 0.125-2, 0.125-4 and 0.0312-2 μg/ml, respectively. Caspofungin was moderately effective, displaying higher variation in MIC values (0.25-64 μg/ml). Voriconazole (2-64 μg/ml) and fluconazole (62.5-500 μg/ml) showed low activity against S. brasiliensis strains. This study contributed to the characterization of the in vitro antifungal susceptibility of strains of S. brasiliensis recovered from cats with sporotrichosis, which have recently been considered the main source of human infections.Entities:
Keywords: Sporothrix brasiliensis; Sporothrix schenckii complex; antifungal susceptibility; cats; sporotrichosis
Mesh:
Substances:
Year: 2015 PMID: 26591009 DOI: 10.1093/mmy/myv039
Source DB: PubMed Journal: Med Mycol ISSN: 1369-3786 Impact factor: 4.076